Obesity Care

Walnut consumption linked to lower obesity rates in young women, study reveals

A recent study conducted by researchers at the Indiana University School of Public Health-Bloomington, USA, and funded by the California Walnut Commission, has uncovered a significant connection between walnut consumption and lower rates of obesity, particularly in younger women. This research highlights the potential role of walnuts and other nuts in promoting healthy weight management.

The study, published in the Current Developments in Nutrition journal, focused on the dietary habits of over 19,000 adolescents and young adults in the United States. The data was drawn from the National Health and Nutrition Examination Survey, encompassing individuals aged between 12 and 19 years for adolescents and 20 and 39 years for young adults. The research aimed to explore the relationship between walnut consumption and obesity-related metrics, including Relative Fat Mass (RFM), a validated tool used to estimate body fat percentage and regional fat distribution.

Dr Carla Miller, a Professor of Nutrition at Indiana University School of Public Health-Bloomington, commented on the findings: “While additional research is needed, these results showed that food should not be judged based on calories alone. The addition of nuts, like walnuts, as a part of a healthy eating pattern, may help lower the risk of obesity.”

She added, “Whether it is a handful as a snack or part of a meal, even in small amounts, nuts, including walnuts, can and should be a part of a nutritious diet to support well-being.”

The study’s findings were particularly striking among young women who regularly consumed walnuts. This group exhibited a significantly lower prevalence of obesity compared to their peers who did not include walnuts or other nuts in their diets. The protective effects of walnuts were less pronounced in other demographic groups. For example, young men and adolescent boys who consumed walnuts did not show a statistically significant reduction in obesity rates. However, adolescent girls and young women who consumed any type of nuts, including walnuts, had a noticeably lower RFM than those who did not consume nuts.

Interestingly, the study revealed an unexpected trend among young men who consumed both walnuts and other types of nuts. This group was found to have a higher likelihood of obesity, a result not observed among adolescent boys. This inverse association suggests that the relationship between nut consumption and obesity may vary based on gender and age, underscoring the complexity of dietary impacts on health.

The researchers caution that while these findings are promising, further studies are needed to confirm the observed associations and better understand the underlying mechanisms. The current research suggests a potential link between a walnut-rich diet and lower body fat levels, but more comprehensive studies are required to establish causality.

One of the study’s notable findings was the generally low consumption of nuts across the population. Despite the potential health benefits, 76% of adolescents and 69% of young adults reported not consuming walnuts daily. Additionally, the average intake of nuts in all groups fell well below the recommended daily amount of 56 to 85 grams. Adolescents averaged just 2 grams per day, while young adults consumed an average of 4 grams per day.

This research adds to a growing body of evidence supporting the health benefits of walnuts. A study conducted last year indicated that regular walnut consumption could improve cognitive development in adolescents with Attention Deficit Hyperactivity Disorder (ADHD). Furthermore, walnuts have been shown to positively influence heart health by stimulating the body’s natural production of the amino acid L-homoarginine, which plays a role in cardiovascular function.

In conclusion, while more research is needed to fully understand the relationship between walnut consumption and obesity, particularly in young women, these findings suggest that incorporating walnuts into a balanced diet could be a valuable strategy for promoting healthy weight management and overall well-being.

New study uncovers brain circuit responsible for balancing hunger and pleasure-driven eating

Humans eat for two primary reasons: to satisfy hunger and for the pleasure derived from food, even when they are not hungry. While hunger-driven eating is essential for survival, pleasure-driven consumption can accelerate the onset of obesity and related metabolic disorders. A groundbreaking study published in Nature Metabolism has identified specific neural circuits in the mouse brain that promote hunger-driven feeding while suppressing pleasure-driven eating. These findings offer promising avenues for developing new strategies to combat obesity.

“Ideal feeding habits would balance eating for necessity and for pleasure, minimising the latter. In this study, we identified a group of neurons that regulate balanced feeding in the brain,” stated Dr. Yong Xu, co-corresponding author, professor of paediatrics – nutrition, and associate director for basic sciences at the USDA/ARS Children’s Nutrition Research Center, Baylor College of Medicine.

Previous research has highlighted the role of neurons marked by the GABAergic proenkephalin (Penk) marker, an endogenous opioid hormone, in regulating feeding and body weight balance. However, their specific role in differentiating hunger-driven and pleasure-driven feeding had not been fully understood.

In this study, Xu and his colleagues demonstrated that activating Penk neurons in a brain region called the diagonal band of Broca (DBB) in male mice promotes an ideal feeding pattern, increasing hunger-driven feeding while reducing pleasure-driven eating.

“I was surprised by this finding,” Xu remarked. “We and other groups had previously shown that certain groups of neurons affect both feeding types in the same way – they either increase or decrease both types. Here, we found that activating DBB-Penk neurons has opposite effects on the two types of feeding; they increase hunger-driven feeding while decreasing eating for pleasure.”

The researchers delved into the mechanisms behind these opposite effects. They discovered that DBB-Penk neurons project into two different brain areas, each regulating a distinct type of feeding behaviour.

“A subset of DBB-Penk neurons that projects to the paraventricular nucleus of the hypothalamus is preferentially activated upon food presentation during fasting periods, facilitating hunger-driven feeding,” Xu explained. “On the other hand, a separate subset of DBB-Penk neurons that projects to a different brain region, the lateral hypothalamus, is preferentially activated when detecting high-fat, high-sugar (HFHS) foods and inhibits their consumption. This is the first study to show a neural circuit that is activated by a reward, HFHS, but leads to terminating instead of continuing the pleasurable activity.”

Remarkably, mice in which the entire DBB-Penk population had been eliminated showed a significant behavioural change. When given a choice between chow and HFHS diets, these mice reduced their consumption of chow but increased their intake of HFHS foods, leading to rapid development of obesity and metabolic disturbances.

“Our findings indicate that the development of obesity is associated with impaired function of some of these brain circuits in mice,” Xu noted. “We are interested in further investigating molecular markers within these circuits that could be suitable targets for the treatment of human diseases such as obesity.”

The study’s contributors include Hailan Liu, Yongxiang Li, Meng Yu, Olivia Z. Ginnard, Kristine M. Conde, Mengjie Wang, Xing Fang, Hesong Liu, Longlong Tu, Na Yin, Jonathan C. Bean, Junying Han, Yongjie Yang, Qingchun Tong, Benjamin R. Arenkiel, Chunmei Wang, and co-corresponding author Yang He, affiliated with institutions such as Baylor College of Medicine, Baylor’s USDA/ARS Children’s Nutrition Research Center, Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, and the University of Texas Health Science Center at Houston.

One-third of NHS diet programme participants achieve type 2 diabetes remission, study finds

A recent study published in The Lancet Diabetes & Endocrinology has revealed that approximately one-third of participants in the National Health Service (NHS) shakes and soups diet programme in England have achieved remission from type 2 diabetes. This study, which evaluated the effectiveness of total dietary replacement (TDR) for insulin-independent diabetes remission, sheds light on the potential of structured diet interventions in managing type 2 diabetes on a large scale.

The escalating rates of diabetes in the United Kingdom have led the NHS to implement the Type 2 Diabetes Path to Remission (T2DR) initiative. This programme is centred around a low-calorie, micronutrient-rich diet, which has been shown to result in significant weight loss and sustained remission of diabetes. While clinical trials have demonstrated the efficacy of such dietary interventions, their effectiveness in broader, real-world contexts has remained unclear until now.

The T2DR programme is designed to help individuals lose weight, maintain that weight loss, and reduce their reliance on glucose-lowering medications. The programme comprises 20 sessions divided into three phases: the TDR phase, the food reintroduction phase, and the weight maintenance phase. The TDR phase, lasting 12 weeks, focuses on strict calorie intake regulation accompanied by coaching. Following this, the food reintroduction phase spans 4 to 6 weeks, during which participants are guided on healthy eating habits and goal-setting. The final phase, weight maintenance, involves monthly coaching sessions aimed at behaviour modification and encouraging physical activity to help participants sustain their weight loss and health improvements.

This study utilised prospective, national-level data to assess whether the NHS’s T2DR programme effectively promotes remission of type 2 diabetes. Researchers analysed data from English adults aged between 18 and 65 who had been diagnosed with type 2 diabetes within the previous six years and were referred to the T2DR programme by their general practitioners between September 2020 and December 2022. Participants included in the study had a body mass index (BMI) of at least 27 kg/m² for white individuals, with a lower threshold of 25 kg/m² for individuals of other ethnicities.

To determine the programme’s effectiveness, the researchers linked programme data with records from the National Diabetes Audit (NDA). They specifically examined glycated haemoglobin (HbA1c) levels and the use of oral hypoglycaemic medications. Eligible participants had recent HbA1c levels ranging from 43 to 87 mmol/mol if they were on glucose-lowering medications, or 48 to 87 mmol/mol if they were not.

The primary outcome of the study was diabetes remission at one year, defined by two HbA1c readings below 48 mmol/mol taken at least three months apart, without the use of glucose-lowering medications. These readings were collected from three months before the initial HbA1c measurement up to 15 months later. Secondary outcomes included the absolute and percentage changes in body weight, as well as the proportion of participants achieving at least 10% and 15% weight loss within one year.

The study focused on participants who began the TDR-based programme before 2022 and had completed it by December 2022, which included having their body weight recorded at the one-year mark. Researchers employed multivariate regression analyses to account for various factors, including demographic characteristics (age, gender, socioeconomic status, and ethnicity), clinical variables (duration of diabetes, baseline BMI, and HbA1c levels), and details about the programme’s delivery method and provider. Sensitivity analyses were also conducted to evaluate different timings for subsequent HbA1c measurements, ranging from 11 to 15 months after the initial reading.

Between September 2020 and December 2022, a total of 7,540 individuals were referred to the T2DR programme. The average age of participants was 50 years, with 43% being male and 64% identifying as white. Of these, 1,740 individuals initiated the TDR phase before 2022, with the aim of completing the programme within one year. Among those who started the programme before 2022, 55% (960 individuals) successfully completed it.

Out of all participants referred to the programme, 34% were not taking glucose-lowering medications, 50% were on one medication, and 16% were on two or more, with metformin being the most commonly prescribed.

The mean weight loss among the 1,710 participants who started the programme before 2022 was 9.40 kg, or 8.3% of their initial body weight. For the 945 participants who completed the programme, the average weight loss increased to 10 kg, or 9.3% of their starting weight. Among those with at least two HbA1c readings, 27% (190 individuals) achieved diabetes remission, with an average weight loss of 15 kg, or 13%. Of the 945 individuals who completed the programme, 48% (450 participants) had two HbA1c readings available, and of these, 32% (145 individuals) achieved remission, with an average weight loss of 16 kg, or 14%.

Furthermore, 42% of the 945 individuals who completed the programme lost at least 10% of their baseline weight, and 20% lost at least 15%. Among those who achieved remission, 76% (110 participants) lost at least 10% of their baseline weight, and 45% (65 participants) lost at least 15%. Sensitivity analyses produced consistent results, reinforcing the findings.

The study concluded that 27% of participants in the NHS T2DR programme achieved diabetes remission, demonstrating that remission is possible outside of controlled research settings with widespread implementation. However, remission rates in real-world applications are lower, and data collection is more limited compared to randomised controlled trials. These findings are significant as they provide valuable insights for policymakers regarding the operational effectiveness of the TDR approach and its potential impact on public health.

Early school-based health education reduces abdominal fat accumulation in children

A groundbreaking study by the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Fundación SHE, with financial support from “la Caixa” Foundation, has unveiled significant findings regarding the prevention of abdominal fat accumulation in children through early, classroom-based health education. The research, documented in the Journal of the American College of Cardiology (JACC), underscores the effectiveness of instilling healthy habits from an early age, positioning primary school as a critical stage for impactful health interventions.

Childhood obesity remains a pressing public health issue, with a notable prevalence in socioeconomically vulnerable groups. Addressing this through school-based programmes has shown mixed results, largely due to varying levels of scientific rigour and implementation fidelity. This study examines the efficacy of a structured health education programme during the formative years of primary education in Madrid, focusing on its ability to curb the rise in obesity markers among young children.

The study engaged 1,771 students from 48 public primary schools in the Comunidad de Madrid. These schools were categorised into four distinct groups. The first group participated in a comprehensive health-promotion programme, the SI! Program–Comprehensive Health, over six years, encompassing emotional management, healthy eating habits, active lifestyles, and basic anatomy and cardiovascular knowledge. The next two groups engaged in the same programme but limited to three-year spans; one from the start and another in the final three years. The fourth group received no specific health interventions. The assessment criteria included body mass index, weight gain, and abdominal fat accumulation, measured at three key stages: at the outset, mid-point, and conclusion of the study.

Results indicated that early intervention (first three years of primary school) was significantly more effective in preventing undesirable increases in body mass index and abdominal fat compared to later interventions or no intervention at all. This early intervention group exhibited the least weight gain and abdominal fat accumulation among all cohorts.

The findings advocate for the strategic placement of health education in the early academic curriculum as a preventive tool against childhood obesity. Rodrigo Fernández-Jiménez, head of the Cardiovascular Health and Imaging laboratory at CNIC and co-author of the study, highlighted the unique position of schools as ideal environments for the execution of such health-promotion programmes. He emphasised the absence of adverse effects and the potential widespread benefits of these interventions.

Gloria Santos-Beneit, the Scientific Director of Fundación SHE and lead author of the study, stated, “The results of this study suggest that interventions promoting healthy lifestyle habits can be more effective at reducing childhood obesity if implemented early, in the first years of elementary school.”

Building upon these insights, Dr. Valentín Fuster, Director General of CNIC, announced the initiation of a new study to explore the efficacy of modified and extended versions of the SI! Program. This new study aims to reduce the burden on educators by incorporating “learning bites” and reintervention strategies throughout the elementary school years, potentially enhancing the sustainability and impact of health education.

This extensive study demonstrates the critical role of early, structured health education in preventing the accumulation of abdominal fat in children. By capitalising on the receptive and formative phase of early education, such interventions can provide a foundation for healthier future generations, underscoring the necessity for well-designed, scalable health-promotion programmes in schools.

CNIC operates under the umbrella of the Carlos III Health Institute (ISCIII), linked to the Spanish Ministry of Science, Innovation, and Universities. Supported by the Pro-CNIC Foundation, it collaborates with major Spanish private entities, consolidating its mission through a pioneering public-private partnership model. The institution has also been honoured as a Severo Ochoa Centre of Excellence, highlighting its pivotal role in cardiovascular research and health promotion.

Exploring the role of the Mediterranean diet in mitigating gestational diabetes risk

A recent comprehensive study published in the journal Nutrition & Diabetes delves into the potential impact of the Mediterranean diet (MedDiet) on reducing the incidence of gestational diabetes mellitus (GDM), a prevalent complication during pregnancy characterised by impaired insulin utilisation due to placental hormones.

GDM not only poses immediate health risks to both mother and child during pregnancy, including heightened risk of birth complications and future chronic conditions, but also contributes to longer-term health issues. Consequently, managing blood glucose levels through medical and dietary measures is essential.

Prevailing research underscores the efficacy of dietary and lifestyle changes in the early stages of pregnancy, or even prior, in averting GDM. Diets high in saturated fats, cholesterol, carbohydrates, and total fats are typically linked to a higher GDM risk.

The Mediterranean diet is noted for its emphasis on whole grains, vegetables, legumes, and foods high in monounsaturated fatty acids (MUFAs), while limiting processed and red meats. Instead of isolating individual dietary components, assessing overall dietary patterns like the MedDiet may offer a holistic approach to managing or preventing GDM.

Numerous studies corroborate that a strict adherence to the MedDiet correlates with a reduced risk of GDM. However, a systematic review and meta-analysis are crucial to consolidate these findings comprehensively.

The current review collated studies up to August 2023 from databases such as PubMed, Web of Science, Google Scholar, and Scopus, excluding duplicates, animal studies, ecological studies, short communications, and non-English articles.

From the selected studies—two case-control and eight cohort studies—conducted in diverse locations including the USA, various Mediterranean countries, Australia, Iran, Spain, and Greece, researchers analysed data from over 32 million participants aged 18 to 45.

The Mediterranean Diet Adherence Screener (MEDAS) score, higher quartiles of alternate MED (AMED) score, and the Mediterranean-Style Dietary Pattern Score (MSDPS) were tools used to assess dietary adherence. GDM outcomes were evaluated using criteria from the National Diabetes Data Group, and through fasting or postprandial blood sugar levels, or glucose challenge tests.

Findings from seven out of ten studies reviewed demonstrated a significant link between higher MedDiet adherence and lower GDM risk, although results varied due to differences in study designs or dietary assessment periods.

Interestingly, while case-control studies reported a substantial 75% reduction in GDM risk among women with higher MedDiet adherence, cohort studies indicated a more moderate 20% risk reduction. The larger reductions noted in case-control studies might stem from recall biases, possibly exaggerating the risk reduction.

Subgroup analyses showed that the benefits of MedDiet adherence in reducing GDM risk applied across both Mediterranean and non-Mediterranean populations, suggesting universal applicability of this dietary pattern.

Higher consumption of whole grains, fruits, vegetables, extra virgin olive oil, nuts, and legumes, alongside regular fish and seafood intake, characterises greater adherence to the MedDiet. This diet, rich in antioxidants and vitamins, mitigates oxidative stress and inflammation, critical factors in chronic disease progression.

The diet’s high polyphenol content in fruits and vegetables plays multiple roles in reducing GDM risk, including glucose absorption inhibition in the gastrointestinal tract, anti-inflammatory properties, microbiota modification, and enhanced antioxidant capacity.

Previous meta-analyses have linked greater MedDiet adherence to reduced obesity or overweight risks by 9%, noting that obesity and insulin resistance are significant GDM risk factors. Additionally, whole grains and nuts, rich in MUFAs and polyunsaturated fatty acids (PUFAs), help regulate blood glucose levels and control appetite.

Observational studies have suggested that long-term red meat consumption may increase GDM risk, further supporting the reduced GDM incidence among those adhering to the MedDiet.

The current systematic review and meta-analysis provide strong evidence supporting the MedDiet’s role in reducing GDM risk when followed before or during pregnancy. It is advisable for women of reproductive age to consider the MedDiet to prevent GDM and other adverse pregnancy outcomes.

Further research should explore the interaction between the MedDiet, genetic factors, and lifestyle elements to refine preventive strategies for GDM.

Alarming surge in severe obesity among adolescents in Ireland

Since 2018, Ireland has witnessed a tenfold increase in referrals of adolescents to specialised obesity clinics, highlighting a critical and worsening health issue among young people. Dr. Órla Walsh, a paediatric specialist at Children’s Health Ireland in Temple Street, has expressed deep concern over the rising number of young patients exhibiting severe symptoms of obesity. Over the past six years, the situation has escalated, with Dr. Walsh noting the overwhelming demand for treatment at her medically-led complex obesity clinic. “I’m running a clinic that is merely the tip of the iceberg. It is a tertiary clinic, which means we only see cases of severe complex obesity that also present with at least two other complications. Since its inception last year, our waiting list has grown to include 419 children,” Dr. Walsh explains.

The pervasive influence of obesity on both the physical and psychological well-being of children is profound. Dr. Walsh stresses that neither the child nor their family is at fault, pointing to genetic factors and an environment that promotes obesity. “The relentless marketing by food and beverage companies significantly contributes to the problem. Our children are inundated with advertisements daily, pushing fast food, processed items, and oversized portions,” she remarks.

A study presented in Dublin last year offered a glimmer of hope, showing promising results from weekly weight loss injections of semaglutide, a medication under the brand names Wegovy and Ozempic. Nearly half of the children treated no longer met the criteria for clinical obesity following the treatment. However, access to such medications is restricted; adolescents can only use these drugs if they are diabetic or if they can afford private treatment, costing approximately £200 a month.

Dr. Walsh highlights the inequality in access to treatment, especially among socioeconomically disadvantaged adolescents. She contrasts the situation in Ireland with international standards where adolescents have access to weight loss medications and bariatric surgery, which are not readily available in Ireland. Efforts have been made to urge the Health Service Executive (HSE) to provide weight loss medication freely to children suffering from complex obesity. “Treating these adolescents can prevent complications later in life. Investing in adolescent health yields a triple benefit: improving their current and future health, and potentially the health of their future children,” Dr. Walsh advocates.

The paediatrician also runs a general adolescent clinic and sees a troubling trend of obesity-related medical complications such as hypertension, pre-diabetes, and obstructive sleep apnoea, along with significant psychiatric comorbidities. “The stigma, shame, and bullying associated with obesity severely affect their mental health, leading to anxiety, depression, and often undiagnosed eating disorders,” she reveals.

Further stressing the urgency, a 2022 international report indicated that Ireland had the highest rate of risk factors for non-communicable diseases in European adolescents. The study surveyed nearly 500,000 children aged between 11 and 17, revealing that 63% of Irish adolescents exhibited four or more risk factors such as physical inactivity, poor diet, and substance use, compared to just 13% of their Swedish counterparts.

Dr. Walsh reflects on her recent observations in Sweden, where a healthier environment for children starkly contrasts with the situation in Ireland. “Sweden offers extensive support for child health, including widespread access to playgrounds, pools, and government-supported child care, which contributes to a healthier societal setup,” she notes.

The article concludes with the HSE’s response on the current status of obesity treatments under consideration for reimbursement, including medications like Saxenda and Wegovy, which are aimed at adults and potentially extendable to adolescents.

Dr. Walsh’s observations and the data presented underscore a dire need for systemic change to combat adolescent obesity in Ireland, a public health challenge that has only intensified in the wake of the global pandemic.

New study finds financial rewards enhance obesity interventions for teens

A recent study has demonstrated that adolescents suffering from severe obesity achieve a more significant reduction in body mass index (BMI) when meal-replacement therapy is supplemented with financial incentives, as opposed to meal-replacement therapy alone. These findings have been documented in an article published by JAMA Pediatrics.

Justin Ryder, PhD, an associate professor involved in both the Surgery Division of Pediatric Surgery and Pediatrics, collaborated on this research. Ryder highlighted the importance of developing more effective treatments for severe obesity, which currently impacts approximately 20% of children and adolescents in the U.S. The Centers for Disease Control and Prevention defines severe obesity as having a BMI at or above the 95th percentile for one’s age and gender. This condition predisposes individuals to a host of future health issues including adult obesity, cardiovascular diseases, and type two diabetes.

Previous studies have shown that meal replacement therapy (MRT), which replaces regular meals with controlled, pre-portioned meals totalling 1,200 calories per day, tends to be more effective than traditional lifestyle changes for reducing BMI in young people with severe obesity. In light of these findings, the recent study aimed to assess whether the addition of financial incentives would enhance the effectiveness of MRT.

“There’s literature for adults that supports that tying in financial incentives to weight loss or physical activity programs increases adherence, and so we wanted to see whether or not adding financial incentives to a behavioural/nutrition weight loss program using meal replacement therapy would increase adherence and through adherence, increase the efficacy of the treatment,” explained Ryder.

The research involved 126 adolescents, divided into two groups of 63 participants each. For one year, one group received MRT along with financial incentives based on their weight reduction from baseline, while the other group received only the MRT. At the end of the 52-week period, the group that received both MRT and financial incentives exhibited a greater decrease in BMI—by 6 percentage points—and a higher reduction in total body fat mass—4.8 kilograms compared to their counterparts who only received MRT.

Ryder added, “Using a cost-effectiveness analysis, we looked at mean fat mass lost between the two treatments and found that despite providing the additional meal replacements for per pound lost, it was cost-effective to do so.”

The study’s authors also noted the need for the development of interventions that maintain effectiveness beyond a one-year timeframe. “While financial incentives plus MRT appears to be a longer-term strategy than MRT alone, treatment withdrawal will likely result in BMI increase. As such, research is needed to identify strategies that are scalable and feasible in the long term given the chronic nature of obesity,” they mentioned.

This pivotal research was funded by multiple grants from the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institutes of Health National Center for Advancing Translational Sciences. Financial support for the meal programs was provided by Healthy For Life Meals, contributing to the resources necessary for this comprehensive study.

Significant weight loss improves metabolism, mood, and decision-making in individuals with obesity

Severe obesity not only predisposes individuals to a variety of health risks but also significantly alters their metabolic functions and psychological states. Historically, it was believed that individuals with severe obesity tended to display heightened impulsivity and a greater propensity for risk-taking. However, recent research conducted by scientists at the DZD partner German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE) has explored whether substantial weight loss could reverse these effects, enhancing both metabolic and psychological conditions and thereby improving decision-making processes. These findings have been elucidated in the publication ‘Clinical Nutrition‘.

Human behaviour is influenced by a myriad of factors including personality traits and internal physiological signals like glucose metabolism and mood states. In individuals with obesity, these internal signals are often disrupted, leading to unreliable decision-making foundations. Beatrix Keweloh, a doctoral researcher in the Department of Neuroscience of Decision and Nutrition, spearheaded an intervention study to investigate if these impairments could be reversed through significant weight loss. The study involved 62 participants, aged 18 to 75, all with severe obesity (BMI > 35 kg/m2). They underwent a rigorous 10-week diet limiting their daily caloric intake to 800 kilocalories.

Measurements of participants’ weight, body fat, mood (via a questionnaire), and risk-taking tendencies (using a computer-based test) were taken at both the start and conclusion of the diet. Results demonstrated a considerable decrease in BMI and HbA1c levels—markers of glucose metabolism—and notable improvements in mood. Additionally, there was a shift towards more risk-averse behaviours, suggesting a direct correlation between BMI and risk behaviour in individuals with obesity. “Our findings also indicated that the metabolic factor HbA1c becomes a predominant predictor of risk-taking behaviours post-weight loss,” commented Beatrix Keweloh.

The study further noted that post-weight loss, mood had a diminished impact on decision-making, with metabolic signals becoming the primary influencers of risk behaviour. “Weight loss positively impacts glucose metabolism and mood, and importantly, restores the regulatory function of glucose metabolism in decision-making processes,” Keweloh summarised.

The interplay between weight loss and the metabolic and psychological factors influencing risk-taking is intricate, with BMI playing a pivotal role. A reduced propensity for risk-taking correlates with a healthier lifestyle, crucial for both achieving and maintaining a healthy body weight. Consequently, interventions aimed at managing weight should incorporate both metabolic and psychological considerations to prevent relapses and foster metabolically driven decisions.

“This study is pioneering as it considers both metabolic and psychological aspects in overweight individuals,” stated Prof. Soyoung Q Park, head of the Department of Neuroscience of Decision and Nutrition. “It marks a significant contribution to the field, although it also highlights the necessity for further research to fully comprehend how energy balance and psychological factors influence our choices.”

Globally, the prevalence of obesity is escalating rapidly. According to a report in the British journal ‘Lancet’, over one billion individuals are affected worldwide, out of a global population of approximately eight billion. Data from the Federal Statistical Office reveal that in Germany alone, around 42 percent of women and 62 percent of men are considered to have either overweight or obesity. The World Health Organization (WHO) classifies individuals with a BMI over 25 as having overweight and over 30 as having obesity.

In studies assessing risk-taking tendencies, various methodologies are employed, such as computerised lottery tasks. In this particular study, a conventional lottery task was utilised where participants made choices between a guaranteed monetary amount and a variable amount, with a 50 percent chance of winning in each scenario.

New clinic for childhood obesity to open in Surrey, UK

Surrey is set to benefit from a pioneering initiative aimed at combating childhood obesity, as revealed by the BBC. The newly established Complications from Excess Weight (CEW) clinic, a part of Ashford and St Peter’s Hospitals NHS Foundation Trust, is preparing to welcome its first referrals in early autumn, 2024.

This service forms part of a broader national strategy, initiated by NHS England in 2022, to open 30 dedicated clinics across the country. These clinics are designed to offer comprehensive support services, including mental health care and nutritional guidance, to children grappling with obesity.

The teams at these clinics will consist of multidisciplinary professionals such as consultant paediatricians, dietitians, and psychologists, who are committed to a holistic treatment approach for the affected children and their families.

Vicky Williams, the Associate Director of Women and Children’s Services at Surrey Heartlands Integrated Care System, highlighted the urgent need for such services: “Obesity affects one in four children in the UK and it can increase the likelihood of a child developing serious health issues.” She emphasised the importance of early intervention and continuous support to prevent future complications. Williams expressed optimism about the local availability of the service, stating, “It means that, in future, children and young people will be referred to a specialist service in Surrey, closer to home, instead of having to travel further away – so it’s good news for families in Surrey.”

Furthermore, the NHS Frimley Integrated Care Board mentioned that currently, children eligible for the CEW clinic’s services in its area are receiving care from consultants based in Southampton. Plans are underway to establish a similar clinic closer to home for patients from Surrey Heath and Farnham, North East Hampshire, and East Berkshire.

The urgent need for such clinics is underscored by alarming statistics; NHS leaders have noted that obesity impacts one in four children in the UK, potentially leading to severe health problems such as Type 2 diabetes, liver disorders, and early onset heart disease. Data from the latest child measurement programme in schools indicates that nearly 13% of children assessed in Surrey during the 2022/23 school year were living with obesity by the time they reached year six of primary school.

Previous governmental measures include the 2018 imposition of a tax on high-sugar soft drinks and limitations on the promotion of unhealthy products in supermarkets across England.

The new Labour government has expressed a firm commitment to addressing this health crisis. A Department for Health and Social Care spokesperson detailed forthcoming measures: “We will introduce tight restrictions on advertising junk food, alongside banning children from being able to purchase sugary, high caffeine energy drinks. By building a healthier society, we will help to build a healthy economy.” This statement underscores the government’s proactive stance on cultivating a healthier future for the next generation.

Examining the impact of excess weight on semen quality

A recent systematic review and meta-analysis published in the International Journal of Obesity, conducted by researchers in China, has revealed the profound impacts of obesity and overweight on male fertility. This study delves into the association between Body Mass Index (BMI) and semen quality, indicating significant adverse effects, particularly in men with more severe levels of obesity. 

Approximately 15% of couples of reproductive age worldwide face infertility issues, with male factors, notably poor semen quality, contributing to 20–70% of these cases. Over recent decades, a marked decline in semen quality has been noted globally. For instance, significant decreases in total sperm count and sperm concentration were observed from 1973 to 2011 in Western nations, and from 1981 to 2019 in China. This decline is influenced by various factors including age, lifestyle, and environmental conditions. An increase in abnormal BMI has been pinpointed as a potential risk factor amidst these changes. Previous studies have linked obesity to reductions in semen quality, but results have varied due to differences in BMI classifications and other methodological limitations.

To address these inconsistencies and provide clearer insights, the researchers included data from 50 human studies, involving a total of 71,337 men aged between 26 and 44 years. These studies were sourced from Embase, PubMed, and Web of Science and categorised men based on their BMI: under 25.0 kg/m² as the reference group, 25.0–29.9 kg/m² as overweight, and over 30.0 kg/m² as having obesity. The studies examined various semen parameters such as volume, sperm concentration, motility, total sperm count, and morphology. Men were also categorised based on their fertility status into general, infertile or sub-fertile, and suspiciously sub-fertile groups.

The analysis, employing statistical tools like the random effects model, Cochran’s Q tests, and I² statistics, demonstrated that obesity was associated with significant reductions in several key semen parameters. Men with obesity, for instance, showed reductions of 0.24 ml in semen volume, 19.56 × 10⁶ in total sperm number, and decreases in both total and progressive motility. Men with overweight experienced milder declines, which were not as widespread across different semen parameters.

The study also highlighted that the detrimental effects of obesity on semen quality varied across different global regions, including America, Asia, and Europe, suggesting regional differences in lifestyle and environmental factors could influence the degree of impact. Furthermore, the findings were consistent across different methods of semen assessment, reinforcing the robustness of the results.

Despite its strengths, such as a large sample size and unified BMI classifications, the study faced limitations related to potential inaccuracies in aggregated data and the BMI’s inability to distinguish between muscle and fat mass. Additionally, the traditional semen parameters used might not fully reflect the functional capacity of sperm.

In conclusion, the analysis confirmed a significant association between higher BMI and poorer semen quality, with more severe impacts observed in men with higher obesity classes. These findings emphasise the importance of maintaining a healthy weight to support male reproductive health and suggest that future studies should explore broader reproductive implications of obesity using more comprehensive indicators of sperm health and function.

Nutritional studies highlight pulses as key to lowering diabetes and cholesterol risks

Research consistently highlights pulses—such as beans, peas, lentils, and chickpeas—as crucial allies in the fight against diabetes and elevated cholesterol levels. This insight comes at a critical time, as projections from a study published in The Lancet last year forecast that diabetes could affect over 1.31 billion people globally by 2050. Concurrently, elevated cholesterol levels remain a significant health issue, with nearly half of adults in the UK exceeding national guidelines.

A detailed review in the journal Nutrients has shown that regular consumption of pulses can significantly improve these concerning health trends. The review meticulously examined thirty studies that looked at various types of pulses, including lentils, chickpeas, and several common beans like pinto, black, and kidney beans. The studies covered a wide array of health outcomes, from lipid profiles and blood pressure to risks of cardiovascular diseases and diabetes management.

The findings from these studies are telling. They specifically note improvements in low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, systolic and diastolic blood pressure, fasting blood sugar, haemoglobin A1c levels, waist circumference, and markers of inflammation and sensitivity such as C-reactive protein. These outcomes particularly underscore the potential of pulses to enhance lipid profiles and manage blood pressure.

The review emphasised that interventional studies, which typically have larger sample sizes and provide robust data, consistently confirm the health benefits of pulses. These studies often involved dietary adjustments where pulses replaced red meat or were added to diets as fixed servings. The results repeatedly demonstrated improvements in dietary quality and beneficial health outcomes.

Pulses’ potential to prevent heart disease is particularly noteworthy, largely due to their ability to lower total and LDL cholesterol levels. The authors of the review highlight that pulses are low in fat and rich in healthy mono- and polyunsaturated fats, essential micronutrients, and bioactive compounds with antioxidant properties, making them a true “nutritional powerhouse.”

Longitudinal studies also link higher pulse consumption with reduced risks of developing type 2 diabetes. This association is bolstered by interventional studies that document notable improvements in fasting glucose levels and insulin sensitivity with increased pulse intake. Consequently, pulses are not only pivotal in preventing diabetes but also in managing blood glucose levels effectively.

Tim McGreevy, CEO of USA Pulses, commented on the research, stating, “This research accentuates the fact that pulses are beneficial for health in so many ways, underscoring dietary guidelines that endorse plant-based eating patterns,” even though he was not directly involved in the study.

Additionally, awareness about type 2 diabetes is critical as many individuals may be unknowingly afflicted. Symptoms to watch for include increased urination, persistent thirst, excessive tiredness, unexplained weight loss, genital itching or recurrent thrush, delayed healing of wounds, and blurred vision. Recognising these signs can prompt earlier intervention and management of the condition, further reducing long-term health risks.

Lifestyle changes in mothers with obesity could mitigate heart risks in offspring

Researchers at King’s College London have discovered that lifestyle modifications could potentially reduce the risk of children developing certain cardiovascular diseases, which are believed to stem from maternal obesity and related foetal heart abnormalities.

Globally, obesity rates among pregnant women are on the rise, with more than half of the women attending antenatal clinics in England and Wales either having overweight (28.5%) or obesity (22.7%). Studies have increasingly shown that obesity during pregnancy can precipitate cardiovascular complications and disrupt normal cardiac development in the offspring.

The findings were detailed in a recent publication in the International Journal of Obesity, led by Dr Samuel Burden. The research team conducted a systematic review of existing studies to explore whether interventions targeting obesity in pregnant women—through diet, exercise, and other physical activities—can foster cardiac health in their children.

The selection criteria for the studies included randomised trials focusing on lifestyle changes among pregnant women diagnosed with obesity. The evidence reviewed indicated that such interventions could avert atypical cardiac development in children, highlighting several benefits commonly associated with improved heart health, such as decreased thickening of the heart walls, maintaining normal heart weight, and reducing the likelihood of increased heart rates.

Dr Samuel Burden commented, “We and others have demonstrated that maternal obesity correlates with signs of poor heart development in children. Our review of existing literature on dietary and exercise interventions in women with obesity, either before or during pregnancy, revealed that these measures indeed offer a protective shield against the extent of this unhealthy heart development in children. Should these results hold into adulthood, these interventions could shield against the detrimental cardiovascular conditions seen in adult children of mothers with obesity, thus guiding public health strategies to enhance cardiovascular health for future generations.”

Although the data supports the premise that lifestyle adjustments in pregnant women with obesity may safeguard infant cardiovascular health, further comprehensive studies are necessary. These should involve larger cohorts and extend into later childhood to affirm the findings and assess if the benefits continue into adulthood.

Should future research corroborate these findings, the implications could be significant, potentially shaping public health initiatives aimed at improving heart health across generations.